Baroreceptor unloading in postural tachycardia syndrome augments peripheral chemoreceptor sensitivity and decreases central chemoreceptor sensitivity.
Indu Taneja, Marvin S Medow, Debbie A Clarke...
https://pubmed.ncbi.nlm.nih.gov/21536847/Actively Recruiting
Led by University of Calgary · Updated on 2026-05-07
26
Participants Needed
1
Research Sites
52 weeks
Total Duration
Postural orthostatic tachycardia syndrome POTS involves various causes, including issues with the sympathetic nervous system. This research aims to see if higher levels of carbon dioxide CO2 can lower heart rate and reduce POTS symptoms when standing. The study also seeks to find the ideal CO2 concentration for the best response. Participants will use the RespirAct system, a device that controls the gases they breathe to adjust blood CO2 levels. The study includes several tilt table tests HUTT with different breathing conditions, including normal breathing, mild and high hypercapnia increased CO2, and fast, deep breathing. All participants receive the same interventions using a face mask connected to the RespirAct system. During the study, participants will be monitored for heart rate changes, cerebral blood flow, and symptom intensity during each tilt test. Data on gas concentrations, breathing rate, and volume will be recorded breath-by-breath. The study also includes safety monitoring for adverse events and keeps participant information confidential. The main measure is heart rate variation during tilt tests, with follow-up lasting through all interventions.
CONDITIONS
Hypercapnia and Orthostatic Tolerance in Postural Orthostatic Tachycardia Syndrome
S
Shaun Ranada, BSc
R
Rasha Hamza, RN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Calgary
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day procedure
Participants undergo a series of tilt tests (HUTT) with different breathing interventions using the RespirAct™ system to assess the effects of hypercapnia on heart rate and symptoms.
1 in-person visit with multiple tilt test sessions
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Indu Taneja, Marvin S Medow, Debbie A Clarke...
https://pubmed.ncbi.nlm.nih.gov/21536847/Anthony J Ocon, Marvin S Medow, Indu Taneja...
https://pubmed.ncbi.nlm.nih.gov/19502561/Julian M Stewart, Paul Pianosi, Mohamed A Shaban...
https://pubmed.ncbi.nlm.nih.gov/29960989/Peter Novak
https://pubmed.ncbi.nlm.nih.gov/30256820/Andrew T Del Pozzi, Christopher E Schwartz, Deepali Tewari...
https://pubmed.ncbi.nlm.nih.gov/24711524/University of Calgary
Lead Sponsor